We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We are an independent review, looking at the 2015 general election to see how well the regulatory system for third party campaigning works.
Information on OPSS product safety alerts, reports and recalls for unsafe products and resources for consumers, businesses and regulators.
Advice for women travelling and living abroad, including organisations that can help.
Advises how to take account of and address the risks associated with flooding and coastal change in the planning process.
Cashflow is an indicator of your company’s health.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
FCDO travel advice for Pitcairn Island. Includes safety and security, insurance, entry requirements and legal differences.
Guidance for businesses.
How to use a case-control study to evaluate your digital health product.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
Evidence-based recommendations to protect first responders from exposure to fentanyl.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
How to use focus groups to evaluate your digital health product.
How end-use controls apply to weapons of mass destruction (WMD) related goods, software, technology and technical assistance.
Our specification documents form the basis of the qualifications linked to SIA licensing.
Tell the CMA about issues with a business, a market, or to provide information about a new or existing case.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.